SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
(Mark One)
( X ) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended: December 31, 1999
----------------------------------
( ) TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
For the transition period from: to
--------------------------
Commission file number: 0-13265
UCI MEDICAL AFFILIATES, INC.
(Exact name of small business issuer as specified in its charter)
Delaware 59-2225346
- ------------------------------------ ----------------
(State or other jurisdiction of incorporation (IRS Employer Identification No.)
or organization)
1901 Main Street, Suite 1200, Mail Code 1105,
Columbia, SC 29201 (Address of principal
executive offices)
(803) 252-3661
(Issuer's telephone number)
(Former name, address or fiscal year, if changed since last report)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. ( X )Yes ( ) No
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13, or 15(d)of the Exchange Act after the distribution of
securities under a plan confirmed by a court. ( )Yes ( ) No
APPLICABLE ONLY TO CORPORATE ISSUERS
State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:
9,650,515 shares of $.05 common stock outstanding at December 31, 1999
Transitional Small Business Disclosure Format (check one): ( )Yes ( X ) No
<PAGE>
UCI MEDICAL AFFILIATES, INC.
INDEX
<TABLE>
<S> <C> <C>
Page
Number
PART I FINANCIAL INFORMATION
Item 1 Financial Statements
Condensed Consolidated Balance Sheets - December 31, 1999
and September 30, 1999 3
Condensed Consolidated Statements of Operations for the quarters
ended December 31, 1999 and December 31, 1998 4
Condensed Consolidated Statements of Cash Flows for the quarters
ended December 31, 1999 and December 31, 1998 5
Notes to Condensed Consolidated Financial Statements 6
Item 2 Management's Discussion and Analysis of Financial
Condition and Results of Operations 8 - 12
Item 3 Quantitative and Qualitative Disclosures About Market Risk 13
PART II OTHER INFORMATION
Items 1-6 14
SIGNATURES 15
</TABLE>
<PAGE>
UCI Medical Affiliates, Inc.
Condensed Consolidated Balance Sheets
<TABLE>
<S> <C> <C>
December 31, 1999 September 30,
1999
------------------- -----------------
(unaudited) (audited)
Assets
Current assets
Cash and cash equivalents $ 229,048 $ 66,159
Accounts receivable, less allowance for doubtful accounts
of $1,156,285 and $1,482,522 8,439,897 8,399,743
Inventory 602,858 590,318
Prepaid expenses and other current assets 914,217 748,467
-------------------
-----------------
Total current assets 10,186,020 ----------------
9,804,687
Property and equipment less accumulated depreciation of
$5,214,524 and $4,921,458 4,725,583 4,796,643
Excess of cost over fair value of assets acquired, less
accumulated amortization of $2,823,331 and $2,650,249 8,538,173 8,711,255
Other assets 41,500 41,500
------------------- -----------------
Total Assets $23,491,276 $23,354,085
=================== =================
Liabilities and Stockholders' Equity
Current liabilities
Book overdraft $ 720,291 $ 803,257
Current portion of long-term debt 5,053,613 4,557,797
Accounts payable 3,300,630 3,341,712
Accrued salaries and payroll taxes 2,619,726 2,292,542
Other accrued liabilities 923,619 ----------------
1,098,859
-----------------
-------------------
Total current liabilities 12,617,879 12,094,167
Long-term debt, net of current portion 4,349,794 4,886,435
------------------- -----------------
Total Liabilities 16,967,673 16,980,602
------------------- -----------------
Commitments and contingencies
Stockholders' Equity
Preferred stock, par value $.01 per share:
Authorized shares - 10,000,000; none issued 0 0
Common stock, par value $.05 per share:
Authorized shares - 10,000,000
Issued and outstanding- 9,650,515 and 9,650,515 shares 482,526 482,526
Paid-in capital 21,723,628 21,723,628
Accumulated deficit (15,682,551) (15,832,671)
------------------- -----------------
Total Stockholders' Equity 6,523,603 6,373,483
------------------- -----------------
Total Liabilities and Stockholders' Equity $23,491,276 $ 23,354,085
=================== =================
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
<PAGE>
UCI Medical Affiliates, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
<TABLE>
<S> <C> <C>
Three Months Ended December 31,
1999 1998
-------------------- ------------------
Revenues $10,198,849 $ 9,681,398
Operating costs 9,218,809 8,337,860
-------------------- ------------------
Operating margin 980,040 1,343,538
General and administrative expenses 25,843 17,817
Depreciation and amortization 466,147 480,513
-------------------- ------------------
Income (loss) from operations 488,050 845,208
Other income (expense)
Interest expense, net of interest income (337,930) (368,481)
Income before benefit (provision ) for income taxes 150,120 476,727
Benefit (provision )for income taxes 0 0
-------------------- ------------------
Net income $ 150,120 $ 476,727
==================
====================
Basic earnings per share $ .02 $ .07
==================== ==================
Basic weighted average common shares outstanding 9,650,515 6,934,517
==================== ==================
Diluted earnings per share $ .02 $ .07
==================== ==================
Diluted weighted average common shares outstanding 9,657,258 6,934,574
==================== ==================
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
<PAGE>
UCI Medical Affiliates, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited)
<TABLE>
<S> <C> <C>
Three Months Ended December 31,
1999 1998
------------------ -----------------
Operating activities:
Net income (loss) $ 150,120 $ 476,727
Adjustments to reconcile net income (loss) to net
cash provided by (used-in) operating activities:
Provision for losses on accounts receivable 403,164 387,238
Depreciation and amortization 466,147 480,513
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable (434,000) (268,722)
(Increase) decrease in inventory (12,540) 0
(Increase) decrease in prepaid expenses and other
current assets (165,750) 202,177
Increase (decrease) in accounts payable and accrued
expenses 101,544 (945,698)
-----------------
------------------
Cash provided by (used in) operating activities 508,685 332,235
------------------ -----------------
Investing activities:
Purchases of property and equipment (222,006) (125,658)
Acquisitions of goodwill 0 (62,674)
(Increase) decrease in other assets 0 360,749
-----------------
------------------
Cash provided by (used in) investing activities (222,006) 172,417
------------------ -----------------
Financing activities:
Net borrowings (payments) under line-of-credit agreement 303,826 (519,938)
Increase (decrease) in book overdraft (82,966) 525,018
Payments on long-term debt (344,650) (461,042)
------------------ -----------------
Cash provided by (used in) financing activities (123,790) (455,962)
------------------ -----------------
Increase (decrease) in cash and cash equivalents 162,889 48,690
Cash and cash equivalents at beginning of period 66,159 335,923
------------------ -----------------
------------------
Cash and cash equivalents at end of period $ 229,048 $ 384,613
================== =================
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
<PAGE>
UCI MEDICAL AFFILIATES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
BASIS OF PRESENTATION:
The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X of the Securities and Exchange Commission. Accordingly, they do
not include all of the information and footnotes required by generally accepted
accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting only of those of a normal recurring
nature) considered necessary for a fair presentation have been included.
Operating results for the three-month period ended December 31, 1999 are not
necessarily indicative of the results that may be expected for the fiscal year
ending September 30, 2000. For further information, refer to the audited
consolidated financial statements and footnotes thereto included in the
Company's annual report on Form 10-K for the year ended September 30, 1999.
The consolidated financial statements include the accounts of UCI Medical
Affiliates, Inc. ("UCI"), UCI Medical Affiliates of South Carolina, Inc.
("UCI-SC"), UCI Medical Affiliates of Georgia, Inc. ("UCI-GA"), Doctor's Care,
P.A., Doctor's Care of Georgia, P.C., and Doctor's Care of Tennessee, P.C. (the
three together as the "P.A."). (As used herein, the term "Company" refers to
UCI, UCI-SC, UCI-GA, and the P.A., collectively.) Because of the corporate
practice of medicine laws in the states in which the Company operates, the
Company does not own medical practices but instead enters into an exclusive
long-term management services agreements with the P.A. which operate the medical
practices. Consolidation of the financial statements is required under Emerging
Issues Task Force (EITF) 97-2 as a consequence of the nominee shareholder
arrangement that exists with respect to each of the P.A.'s. In each case, the
nominee (and sole) shareholder of the P.A. has entered into an agreement with
UCI-SC or UCI-GA, as applicable, which satisfies the requirements set forth in
footnote 1 of EITF 97-2. Under the agreement, UCI-SC or UCI-GA, as applicable,
in its sole discretion, can effect a change in the nominee shareholder at any
time for a payment of $100 from the new nominee shareholder to the old nominee
shareholder, with no limits placed on the identity of any new nominee
shareholder and no adverse impact resulting to any of UCI-SC, UCI-GA or the P.A.
resulting from such change.
In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA have entered into Administrative Service Agreements with the
P.A.'s. As a consequence of the nominee shareholder arrangements and the
Administrative Service Agreements, the Company has a long-term financial
interest in the affiliated practices of the P.A.'s. Through the Administrative
Services Agreement, the Company has exclusive authority over decision making
relating to all major on-going operations. The Company establishes annual
operating and capital budgets for the P.A. and compensation guidelines for the
licensed medical professionals. The Administrative Services Agreements have an
initial term of forty years. According to EITF 97-2, the application of FASB
Statement No. 94 (Consolidation of All Majority-Owned Subsidiaries), and APB No.
16 (Business Combinations), the Company must consolidate the results of the
affiliated practices with those of the Company. All significant intercompany
accounts and transactions are eliminated in consolidation, including management
fees.
The method of computing the management fees is based on billings of the
affiliated practices less the amounts necessary to pay professional compensation
and other professional expenses. In all cases, these fees are meant to
compensate the Company for expenses incurred in providing covered services, plus
a profit. These interests are unilaterally salable and transferable by the
Company and fluctuate based upon the actual performance of the operations of the
professional corporation.
The P.A. enters into employment agreements with physicians for terms ranging
from one to ten years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license. Over 79% of the physicians employed by the P.A. are paid on an
hourly basis for time scheduled and worked at the medical centers, while other
physicians are salaried. Approximately 25 of the physicians have incentive
compensation arrangements which are contractually based upon factors such as
productivity, collections and quality.
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and revenues and expenses
and the disclosure of contingent assets and liabilities. Actual results could
differ from those estimates and assumptions. Significant estimates are discussed
in the footnotes, as applicable, of the Form 10-K for the year ended September
30, 1999.
The Company operates as one segment.
EARNINGS PER SHARE
The computation of basic earnings (loss) per share and diluted earnings (loss)
per share is in conformity with the provisions of Statement of Financial
Accounting Standards No. 128.
<PAGE>
PART I
FINANCIAL INFORMATION
ITEM 2
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following discussion and analysis provides information, which the Company
believes, is relevant to an assessment and understanding of the Company's
consolidated results of operations and financial condition. This discussion
should be read in conjunction with the consolidated financial statements and
notes thereto.
The consolidated financial statements of the Company include the accounts of
UCI, UCI-SC, UCI-GA and the P.A.'s. Such consolidation is required under
Emerging Issues Task Force (EITF) 97-2 as a consequence of the nominee
shareholder arrangement that exists with respect to each of the PA's. In each
case, the nominee (and sole) shareholder of the P.A. has entered into an
agreement with UCI-SC or UCI-GA, as applicable, which satisfies the requirements
set forth in footnote 1 of EITF 97-2. Under the agreement, UCI-SC or UCI-GA, as
applicable, in its sole discretion, can effect a change in the nominee
shareholder at any time for a payment of $100 from the new nominee shareholder
to the old nominee shareholder, with no limits placed on the identity of any new
nominee shareholder and no adverse impact resulting to any of UCI-SC, UCI-GA or
the P.A. resulting from such change.
In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA have entered into Administrative Service Agreements with the
P.A.'s. As a consequence of the nominee shareholder arrangements and the
Administrative Service Agreements, the Company has a long-term financial
interest in the affiliated practices of the P.A.'s. According to EITF 97-2, the
application of FASB Statement No. 94 (Consolidation of All Majority-Owned
Subsidiaries), and APB No. 16 (Business Combinations), the Company must
consolidate the results of the affiliated practices with those of the Company.
The P.A.'s enter into employment agreements with physicians for terms ranging
from one to ten years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license. Over 79% of the physicians employed by the P.A.'s are paid on
an hourly basis for time scheduled and worked at the medical centers. The other
physicians are salaried. Approximately 25 of the physicians have incentive
compensation arrangements; however, no amounts were accrued or paid during the
Company's three prior fiscal years that were significant. Any incentive
compensation is based upon a percentage of non-ancillary collectible charges for
services performed by a provider. Percentages range from 3% to 17% and vary by
individual employment contract. As of December 31, 1999 and 1998, the P.A.'s
employed 121 and 95 medical providers, respectively.
The net assets of the P.A.'s are not material for any period presented, and
intercompany accounts and transactions have been eliminated.
The Company does not allocate all indirect costs incurred at the corporate
offices to the Centers on a center-by-center basis. Therefore, all discussions
below are intended to be in the aggregate for the Company as a whole.
Results of Operations
Revenues of $10,199,000 for the quarter ended December 31, 1999 reflect an
increase of 5% from those of the quarter ended December 31, 1998.
This increase in revenue is the result of "same-store" growth in patient visits
and patient charges. The same 41 locations were operating at both December 31,
1999 and December 31, 1998. Patient encounters increased to approximately
131,000 in the first quarter of fiscal year 2000 from 127,000 in the first
quarter of fiscal year 1999.
During the past three fiscal years, the Company has continued its services
provided to members of HMOs. In these arrangements, the Company, through the
P.A., acts as the designated primary caregiver for members of HMOs who have
selected one of the Company's centers or providers as their primary care
provider. In fiscal year 1994, the Company began participating in an HMO
operated by Companion HealthCare Corporation ("CHC"), a wholly owned subsidiary
of Blue Cross Blue Shield of South Carolina ("BCBS"). BCBS, through CHC, is a
primary stockholder of UCI. Including its arrangement with CHC, the Company now
participates in four HMOs and is the primary care "gatekeeper" for more than
20,000 lives at December 31, 1999. One of these HMOs uses a capitation scheme
for payments and three pay on a discounted fee-for-service basis. HMOs do not,
at this time, have a significant penetration into the South Carolina market. The
Company is not certain if there will be growth in the market share of HMOs in
the areas in which it operates clinics. Capitated revenue decreased from
approximately $360,000 in the first quarter of fiscal year 1999 to approximately
$340,000 in the first quarter of fiscal year 2000.
The Company currently negotiates contracts with one HMO for the P.A.'s
physicians to provide health care on a capitated reimbursement basis. Under
these contracts, which typically are automatically renewed on an annual basis,
the P.A. physicians provide virtually all covered primary care services and
receive a fixed monthly capitation payment from the HMOs for each member who
chooses a P.A. physician as his or her primary care physician. The capitation
amount is fixed depending upon the age and sex of the HMO enrollee. Contracts
with capitated HMOs accounted for approximately 3% of the Company's net revenue
in the first quarter of fiscal year 2000 compared to 4% the first quarter of
fiscal year 1999.
To the extent that enrollees require more care than is anticipated, aggregate
capitation payments may be insufficient to cover the costs associated with the
treatment of enrollees. No capitation contracts currently in place at the
Company have been determined to be insufficient to cover related costs of
treatment. Higher capitation rates are typically received for senior patients
because their medical needs are generally greater and consequently the cost of
covered care is higher.
Increased and sustained revenues in fiscal years 2000 and 1999 also reflect the
Company's heightened focus on occupational medicine and industrial health
services (these revenues are referred to as "employer paid" on the table below).
Focused marketing materials, including quarterly newsletters for employers, were
developed to spotlight the Company's services for industry.
The following table breaks out the Company's revenue and patient visits by
revenue source for the first quarter of fiscal years 2000 and 1999.
<TABLE>
<S> <C> <C> <C> <C> <C>
Percent of Percent of
Payor Patient Visits Revenue
------------------------------------------------ ------------------------ -----------------------
2000 1999 2000 1999
------------ ----------- ------------ ----------
17 19 16 19
Patient Pay
9 11 5 8
Employer Paid
13 10 15 10
HMO
6 8 12 12
Workers Compensation
8 10 6 7
Medicare/Medicaid
38 34 33 34
Managed Care Insurance
9 8 13 10
Other (Commercial Indemnity, Champus, etc.)
</TABLE>
An operating margin of $980,000 was earned during the first quarter of fiscal
2000 as compared to an operating margin of $1,344,000 for the first quarter of
fiscal 1999.
Management believes that the decline in margin was the result of personnel and
supply costs overruns that it is in the process of reducing. However, the
personnel cost increases are in part attributable to increased cost-cutting
pressures being applied by managed care insurance payors that cover many of the
Company's patients. As managed care plans attempt to cut costs, they typically
increase the administrative burden of providers such as the Company by requiring
referral approvals and by requesting hard copies of medical records before they
will pay claims. The number of patients at the Company's Centers that are
covered by a managed care plan versus a traditional indemnity plan continues to
grow. Management expects this trend to continue.
Depreciation and amortization expense decreased to $466,000 in the first quarter
of fiscal 2000, down from $481,000 in the first quarter of fiscal 1999. This
decrease reflects higher depreciation expense as a result of leasehold
improvements and equipment upgrades at a number of the Company's medical
centers, offset by a greater reduction in amortization expense for fully
amortized acquisitions. Interest expense decreased from $368,000 in the first
quarter of fiscal 1999 to $338,000 in the first quarter of fiscal 2000 primarily
as a result of the overall reduction in long-term debt.
Going Concern Matters
The accompanying financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. As shown in the financial
statements, the Company has a working capital deficiency, an accumulated
deficit, and the line of credit agreement which expires in March 2000 and the
Company currently is in violation of a loan covenant related to its line of
credit. Ultimately, the Company's viability as a going concern is dependent upon
its ability to continue to generate positive cash flows from operations,
maintain adequate working capital and obtain satisfactory long-term financing.
The financial statements do not include any adjustments relating to the
recoverability and classification of liabilities that might be necessary should
the Company be unable to continue as a going concern. The Company plans include
the following, although it is not possible to predict the ultimate outcome of
the Company's efforts.
The Company is currently seeking sources of financing from other financing
sources with terms more suitable and favorable to the Company's financing
requirements. The Company anticipates that a new financing arrangement will be
in place prior to the expiration of the current line of credit agreement. The
Company management believes that due to the improved financial results for
fiscal year 1999 and the first quarter of fiscal year 2000 and the existence of
an adequate asset base, lenders will be interested in finalizing a financial
agreement. The Company expects to have availability of the existing line of
credit until the expiration date of the credit agreement.
Financial Condition at December 31, 1999
Cash and cash equivalents increased by $163,000 during the quarter ended
December 31, 1999 mainly as a result of the continuing profitability.
Accounts receivable increased slightly during the quarter, reflecting the slight
growth in revenue.
The reduction in goodwill is attributable to regularly scheduled amortization.
Long-term debt decreased from $9,444,000 at September 30, 1999 to $9,403,000 at
December 31, 1999. Regular principal pay-downs of approximately $345,000 during
the quarter were offset by a temporary increase in the Company's line of credit
balance. This balance fluctuates daily. Management believes that it will be able
to fund debt service requirements out of cash generated through operations.
Liquidity and Capital Resources
The Company requires capital principally to fund growth (acquire new Centers),
for working capital needs and for the retirement of indebtedness. The Company's
capital requirements and working capital needs have been funded through a
combination of external financing (including bank debt and proceeds from the
sale of common stock to CHC and CP&C), and credit extended by suppliers.
The Company has a $7,000,000 bank line of credit with an outstanding
indebtedness of approximately $3,200,000 at December 31, 1999. The availability
under this line of credit is limited by accounts receivable type and age as
defined in the agreement. As of December 31, 1999, the Company had borrowed
approximately the maximum allowable amounts. The line of credit bears interest
of prime plus 2.5% with a maturity of March 2000. (Prime rate was 8.50% at
December 31, 1999.) The line of credit is used to fund the working capital needs
of the Company. At December 31, 1999, the Company is in default of a debt
covenant related to the line of credit in regard to a net worth. The covenant
requires that net worth of the Company not drop below $7,650,000. The Company
believes, but cannot be certain, that the financial institution does not intend
to take action related to this default and continues to utilize the line on a
daily basis. This line of credit expires under its original terms on March 24,
2000 and the Company is currently in negotiations with its current lender and
various other potential lenders to refinance this debt. It is, therefore, being
temporarily classified as current.
As of December 31, 1999, the Company had no material commitments for capital
expenditures or for acquisition or start-ups.
Operating activities produced $509,000 of cash during the first quarter of
fiscal year 2000, compared with $332,000 during the first quarter of fiscal year
1999.
Investing activities produced $172,000 in the first quarter of fiscal year 1999
in cash mainly as the result of the Company selling a piece of investment
property for approximately $225,000 (sold for approximately the recorded book
value).
Financing activities utilized $345,000 in cash during the quarter for debt
reduction offset by an approximate $304,000 increase in the line of credit that
was temporary in nature due to the daily fluctuation of the primary line of
credit.
The Year 2000
During the years leading up to the Year 2000, an important business issue arose
over the concern that the Company's computer systems, or other business systems,
or those of the Company's vendors, working either alone or in conjunction with
other software or systems, would fail to, or work incorrectly, accept input of,
store, manipulate or output dates in the years 1999, 2000 or thereafter
(commonly known as the "Year 2000" problem). In response, the Company conducted
a review of its business systems, including its computer systems, on a
system-by-system basis, and queried third parties with whom it conducts business
as to their progress in identifying and addressing problems that their computer
systems might face in correctly processing date information. The Company
reviewed its information technology ("IT") hardware and software, including
personal computers, application and network software for Year 2000 compliance
readiness. The review process entailed evaluation of hardware/software and
testing. The cost to bring the Company's IT systems into Year 2000 compliance
was approximately $25,000.
The Company determined that its general accounting systems (which includes
invoicing, accounts receivable, payroll, etc.) needed to be upgraded to make the
systems Year 2000 compliant. The Company has upgraded their system at a cost of
approximately $20,000.
The Company also reviewed its non-IT systems (including voice communications).
The costs to remedy non-IT systems was not material. The source of funds for
evaluation and remediation of Year 2000 compliance issues was cash flow from
operations.
The third parties whose Year 2000 problems could have the greatest effect on the
Company are believed by the Company to be banks that maintain the Company's
depository accounts' credit card processing systems (including related
telecommunication systems), the companies which supply the Company with medical
supplies, and the insurance company payors for the Company's patients' medical
claims. To date, however, the Company is not aware of the failure of any of the
systems of these third parties relating to Year 2000 problems.
Evidence of system performance in the IT and non-IT systems of the Company and
third parties with whom it conducts business following January 1, 2000 indicates
that most of the areas of exposure to system malfunctions associated with Year
2000 issues have been properly addressed. Nevertheless, there can be no
assurance that the Company has identified all Year 2000 problems in its computer
systems or those of third parties in advance of their occurrence or that the
Company will be able to successfully remedy any problems that are discovered.
The expenses of the Company's efforts to identify and address such problems, or
the expenses or liabilities to which the Company may become subject as a result
of such problems, could have a material adverse effect on the Company's
business, financial condition and results of operations. Any additional
maintenance or modification costs will be expensed as incurred.
Advisory Note Regarding Forward-Looking Statements
Certain of the statements contained in this PART I, Item 2 (Management's
Discussion and Analysis of Financial Condition and Results of Operations) that
are not historical facts are forward-looking statements subject to the safe
harbor created by the Private Securities Litigation Reform Act of 1995. The
Company cautions readers of this Quarterly Report on Form 10-Q that such
forward-looking statements involve known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or achievements of
the Company to be materially different from those expressed or implied by such
forward-looking statements. Although the Company's management believes that
their expectations of future performance are based on reasonable assumptions
within the bounds of their knowledge of their business and operations, there can
be no assurance that actual results will not differ materially from their
expectations. Factors which could cause actual results to differ from
expectations include, among other things, the difficulty in controlling the
Company's costs of providing healthcare and administering its network of
Centers; the possible negative effects from changes in reimbursement and
capitation payment levels and payment practices by insurance companies,
healthcare plans, government payors and other payment sources; the difficulty of
attracting primary care physicians; the increasing competition for patients
among healthcare providers; possible government regulations negatively impacting
the existing organizational structure of the Company; the possible negative
effects of prospective healthcare reform; the challenges and uncertainties in
the implementation of the Company's expansion and development strategy; the
dependence on key personnel, the ability to successfully integrate the
management structures and consolidate the operations of recently acquired
entities or practices with those of the Company, and other factors described in
this report and in other reports filed by the Company with the Securities and
Exchange Commission.
<PAGE>
ITEM 3
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is exposed to changes in interest rates primarily as a result of its
borrowing activities, which includes credit facilities with financial
institutions used to maintain liquidity and fund the Company's business
operations, as well as notes payable to various third parties in connection with
certain acquisitions of property and equipment. The nature and amount of the
Company's debt may vary as a result of future business requirements, market
conditions and other factors. The definitive extent of the Company's interest
rate risk is not quantifiable or predictable because of the variability of
future interest rates and business financing requirements. The Company does not
currently use derivative instruments to adjust the Company's interest rate risk
profile.
Approximately $5,500,000 of the Company's debt at December 31, 1999 was subject
to fixed interest rates and principal payments. Approximately $4,000,000 of the
Company's debt at December 31, 1999 was subject to variable interest rates.
Based on the outstanding amounts of variable rate debt at December 31, 1999, the
Company's interest expense on an annualized basis would increase approximately
$40,000 for each increase of one percent in the prime rate.
The Company does not utilize financial instruments for trading or other
speculative purposes, nor does it utilize leveraged financial instruments.
<PAGE>
PART II
OTHER INFORMATION
Item 1 Legal Proceedings
The Company is not a party to any pending litigation other
than routine litigation incidental to the business or that,
which is immaterial in amount of damages sought.
Item 2 Changes in Securities
This item is not applicable.
Item 3 Defaults upon Senior Securities
This item is not applicable.
Item 4 Submission of Matters to a Vote of Security Holders
This item is not applicable.
Item 5 Other Information
This item is not applicable.
Item 6 Exhibits and Reports on Form 8-K
(a) Exhibits. The exhibits included on the attached Exhibit Index are
filed as part of this report.
(b) Reports on Form 8-K.
None.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
UCI Medical Affiliates, Inc.
(Registrant)
/s/ M.F. McFarland, III, M.D. /s/ Jerry F. Wells, Jr.
- ----------------------------- -----------------------
Marion F. McFarland, III, M.D. Jerry F. Wells, Jr.
President, Chief Executive Officer, Executive Vice President of Finance,
and Chairman of the Board Chief Financial Officer and
Principal Accounting Officer
Date: February 14, 2000
<PAGE>
UCI MEDICAL AFFILIATES, INC.
EXHIBIT INDEX
<TABLE>
<S> <C> <C>
EXHIBIT NUMBER
DESCRIPTION PAGE NUMBER
- ----------------- ------------------------------------------------------- ------------------------------------
27 Financial Data Schedule Filed separately as Article Type 5
via Edgar
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
(Replace this text with the legend)
</LEGEND>
<CIK> 0000737561
<NAME> UCI Medical Affiliates, Inc.
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 229,048
<SECURITIES> 0
<RECEIVABLES> 8,439,897
<ALLOWANCES> 1,156,285
<INVENTORY> 602,858
<CURRENT-ASSETS> 10,186,020
<PP&E> 4,725,583
<DEPRECIATION> 5,214,524
<TOTAL-ASSETS> 23,491,276
<CURRENT-LIABILITIES> 12,617,879
<BONDS> 0
0
0
<COMMON> 482,526
<OTHER-SE> 6,041,077
<TOTAL-LIABILITY-AND-EQUITY> 23,491,276
<SALES> 0
<TOTAL-REVENUES> 10,198,849
<CGS> 0
<TOTAL-COSTS> 8,815,645
<OTHER-EXPENSES> 491,990
<LOSS-PROVISION> 403,164
<INTEREST-EXPENSE> 337,930
<INCOME-PRETAX> 150,120
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 150,120
<EPS-BASIC> .02
<EPS-DILUTED> .02
</TABLE>
